Your Location:
Home >
Browse articles >
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
- Military Medical Research Vol. 9, Issue 2, Pages: 215-230(2022)
DOI: 10.1186/s40779-021-00342-3
Scan QR Code
Full Text(HTML)
Figs( 1 ) Tabs( 1 )
References
Publication Info
Metrics
19
Views
18
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Advances in the design and development of SARS-CoV-2 vaccines
A cross-sectional study of olfactory and taste disorders among COVID-19 patients in China
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China
Development of rapid advice guideline and standard and continuous updating guideline: experiences and practice
Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion
Related Author
Dai-Xu Wei
Xue-Liang Peng
Ji-Si-Yu Cheng
Hai-Lun Gong
Xiao-Hong Zhao
Zibiao Li
Meng-Di Yuan
Hu Yuan
Related Institution
Institute of Materials Research and Engineering, A*STAR (Agency for Science, Technology and Research), 2 Fusionopolis Way, Innovis, #08-03
Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Department of Life Sciences and Medicine, Northwest University
Department of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital Hainan Hospital
National Clinical Research Center for Otolaryngologic Diseases, No. 28 Fuxing Road
College of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital

